SEQH Capital Research

SEQH Capital Research

Supply-Chain Centrality: ASPI/QLE as a Western Isotope Sovereignty Platform

5/2/26

SEQH Capital Research's avatar
SEQH Capital Research
May 02, 2026
∙ Paid

SEQH CAPITAL RESEARCH - TEAR SHEET
ASP ISOTOPES / QUANTUM LEAP ENERGY - A WESTERN ISOTOPE SOVEREIGNTY PLATFORM

WHAT THIS REPORT ANSWERS

  • The report reframes ASP Isotopes (ASPI) and Quantum Leap Energy (QLE) as a Western isotope and nuclear fuel network node, not just a set of individual isotope products, and values the platform by how much supply chain value at risk (VaR) it removes for Western customers.

  • SEQH models a baseline annualized disruption loss of about 352 million dollars across five isotope and fuel buckets and shows that adding ASPI’s South African isotope node plus QLE’s Texas and UK nodes could cut that to about 259 million dollars, a 26 percent VaR compression that underpins a 9 to 32 million dollar yearly shadow willingness to pay pool.

Core thesis

  • Political and industrial policy momentum is shifting toward isotope sovereignty and HALEU sovereignty as hidden enablers of quantum computing, advanced reactors, nuclear medicine and fusion, with DOE explicitly funding isotope programs and 2.7 billion dollars of LEU and HALEU capacity.

  • ASPI and QLE sit at the intersection: ASPI targets first commercial shipments in 2026across Si 28, C 14 and Yb 176, while QLE is pursuing HALEU, LEU plus, LEU and lithium 6 and 7 separation from South Africa into Texas and the UK, making the combined platform a candidate Western redundancy provider for both isotopes and fuel.

  • The key shift versus earlier work is to analyze ASPI/QLE as a VaR reducer where node value equals expected downstream loss removed, not simply volume times price, which justifies premium contractual structures over pure spot sales.

VaR model and buckets

  • SEQH defines annual supply chain VaR per bucket as Flow Value times Disruption Probability times Loss Severity times Chokepoint Exposure, then applies an ASPI/QLE substitution coverage times execution confidence factor to estimate how much of that VaR can be reduced once nodes are credible.

  • Baseline VaR across five buckets is about 212.6 million dollars for HALEU and LEU plus, 85.8 million dollars for Si 28 and germanium quantum materials, 39.6 million dollars for Yb 176 and Lu 177, 10.8 million dollars for Xe 129, and 2.9 million dollars for C 14, totaling roughly 351.7 million dollars.

  • After ASPI’s Pretoria isotope ramp alone, VaR drops modestly, but after adding the Texas HALEU facility concept and UK HALEU and lithium pathway, modeled VaR falls to about 259.2 million dollars, a 92.5 million dollar reduction dominated by HALEU and Si 28 buckets.

Facility map and centrality

  • The platform spans three jurisdictions: Pretoria for stable isotope enrichment in Si 28, C 14 and Yb 176, Pelindaba / Gauteng for QLE and Necsa uranium enrichment R and D and future HALEU, Carson County, Texas as a proposed U.S. HALEU enrichment facility with Fermi America, and the UK as an allied HALEU and lithium laser R and D node.

  • Pretoria is the near term proof node for Western aligned isotope redundancy, Texas addresses the largest VaR bucket by colocating HALEU with U.S. grid and data center infrastructure, and the UK adds regulatory and fusion fuel optionality that single site competitors lack.

Shadow willingness to pay and contracts

  • SEQH interprets the 92.5 million dollar VaR reduction as a shadow willingness to pay pool rather than revenue, and shows that at 10, 20 and 35 percent supplier capture rates it implies about 9.3, 18.5 and 32.4 million dollars of annual premium value that can be shared via contracts.

  • The already disclosed C 14 take or pay deal at about 2.5 million dollars per year is presented as a template for how strategic isotope buyers pay for availability and assurance rather than just spot volume.

  • The report argues that higher value structures for larger buckets should include take or pay off take, prepaid qualification inventory, government backed procurement and cost share, and strategic campus integration such as the Fermi America 11 GW private grid and HALEU campus concept.

Risks and what changes the model

  • The biggest execution risks are missed 2026 shipments across Si 28, C 14 and Yb 176, delays in Texas and UK HALEU licensing and siting, and the possibility that other DOE backed vendors capture most of the HALEU redundancy economics.

  • Model uncertainty is acknowledged for China linked germanium flows and non public Si 28 qualification economics, so the framework keeps assumptions explicit and gives more conservative substitution credit where public data are weaker.

  • Key positive catalysts are successful first shipments and customer qualification for Si 28, Yb 176 and C 14, visible progress on the Texas HALEU facility and UK regulatory engagement, and the January 1, 2028 expiry of Russian uranium import waivers, which should raise urgency for non Russian enrichment.

FULL 18-PAGE ASPI/QLE REPORT LOCATED BELOW:

User's avatar

Continue reading this post for free, courtesy of SEQH Capital Research.

Or purchase a paid subscription.
© 2026 SEQH Capital Partners · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture